Medical Journals

Stimulation of A2a-adenosine Receptors After Myocardial Infarction Suppresses Inflammatory Activation and Attenuates Contractile Dysfunction in the Remote Left Ventricle.

Authors:
  • Toufektsian Marie-Claire
  • Yang Zequan
  • Prasad Konkal M
  • Overbergh Lutgart
  • Ramos Susan I
  • Mathieu Chantal
  • Linden Joel
  • French Brent A

From: Dept. of Biomedical Engineering, University of Virginia, Charlottesville, VA 22908, USA.

American journal of physiology. Heart and circulatory physiology

  • Publish Date: Apr 2006
  • ISSN: 0363-6135
  • Volume: 290
  • Issue: 4
  • Pages: H1410-8
  • Medium: Print
  • Language: English
  • Citation (JAMA): Toufektsian Marie-Claire, Yang Zequan, Prasad Konkal M, et al. Stimulation of A2a-adenosine Receptors After Myocardial Infarction Suppresses Inflammatory Activation and Attenuates Contractile Dysfunction in the Remote Left Ventricle.. Am. J. Physiol. Heart Circ. Physiol. Apr 2006;290:H1410-8

Abstract

Following myocardial infarction (MI), contractile dysfunction develops not only in the infarct zone but also in noninfarcted regions of the left ventricle remote from the infarct zone. Inflammatory activation secondary to MI stimulates inducible nitric oxide synthase (iNOS) induction with excess production of nitric oxide. We hypothesized that the anti-inflammatory effects of selective A(2A)-adenosine receptor (A(2A)AR) stimulation would suppress inflammation and preserve cardiac function in the remote zone early after MI. A total of 53 mice underwent 60 min of coronary occlusion followed by 24 h of reperfusion. The A(2A)AR agonist (ATL146e, 2.4 microg/kg) was administered intraperitoneally 1, 3, and 6 h postreperfusion. Because of the 1-h delay in treatment after MI, ATL146e had no effect on infarct size, as demonstrated by contrast-enhanced cardiac MRI (n = 18) performed 24 h post-MI. ATL146e did however preserve global cardiac function at that time by limiting contractile dysfunction in remote regions [left ventricle wall thickening: 51 +/- 4% in treated (n = 9) vs. 29 +/- 3% in nontreated groups (n = 9), P < 0.01]. RT-PCR, immunohistochemistry, and Western blot analysis indicated that iNOS mRNA and protein expression were significantly reduced by ATL146e treatment in both infarcted and noninfarcted zones. Similarly, elevations in plasma nitrate-nitrite after MI were substantially blunted by ATL146e (P < 0.01). Finally, treatment with ATL146e reduced NF-kappaB activation in the myocardium by over 50%, not only in the infarct zone but also in noninfarcted regions (P < 0.05). In conclusion, A(2A)AR stimulation after MI suppresses inflammatory activation and preserves cardiac function, suggesting the potential utility of A(2A)AR agonists against acute heart failure in the immediate post-MI period.

Mesh Headings (Keywords): Animals, Cytokines, Mice, Myocardial Contraction, Myocardial Reperfusion Injury, Nitric Oxide Synthase Type II, Receptor, Adenosine A2A, Tissue Distribution, Ventricular Dysfunction, Left


Check for Full Text / PubMed Unique Identifier (PMID): 16284233


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.